S-phase-specific interaction of the Fanconi anemia protein, FANCD2, with BRCA1 and RAD51

Blood

Volumn 100, Issue 7, 2002, Pages 2414-2420

  Taniguchi, Toshiyasu ^a,b   Garcia Higuera, Irene ^a,b   Andreassen, Paul R ^a,b   Gregory, Richard C ^a,b   Grompe, Markus ^a,b   D'Andrea, Alan D ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BRCA1 PROTEIN; CELL DNA; CELL PROTEIN; FANCONI ANEMIA PROTEIN; RAD51 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CELL CYCLE S PHASE; CONTROLLED STUDY; DNA DAMAGE; DNA REPAIR; FANCONI ANEMIA; HELA CELL; HOMOLOGOUS RECOMBINATION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DNA INTERACTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION;

EID: 0036785375     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-01-0278     Document Type: Article

References (43)

1. Joenje H, Patel KJ. The emerging genetic and molecular basis of Fanconi anaemia. Nat Rev Genet. 2001;2:446-459.
2. Grompe M, D'Andrea A. Fanconi anemia and DNA repair. Hum Mol Genet. 2001;10:2253-2259.
3. Duckworth-Rysiecki G, Taylor AMR. Effects on ionizing radiation on cells from Fanconi's anemia patients. Cancer Res. 1985;45:416-420.
4. Carreau M, Alon N, Bosnoyan-Collins L, Joenje H, Buchwald M. Drug sensitivity spectra in Fanconi anemia lymphoblastoid cell lines of defined complementation groups. Mutat Res. 1999;435:103-109.
5. Joenje H, Levitus M, Waisfisz Q, et al. Complementation analysis in Fanconi anemia: assignment of the reference FA-H patient to group A. Am J Hum Genet. 2000;67:759-762.
6. Timmers C, Taniguchi T, Hejna J, et al. Positional cloning of a novel Fanconi anemia gene, FANCD2. Mol Cell. 2001;7:241-248.
7. Lo Ten Foe JR, Rooimans MA, Bosnoyan-Collins L, et al. Expression cloning of a cDNA for the major Fanconi anemia gene, FAA. Nat Genet. 1996;14:320-323.
8. Fanconi-Anemia/Breast-Cancer-Consortium. Positional cloning of the Fanconi Anaemia Group A gene. Nat Genet. 1996;14:324-328.
9. Strathdee CA, Gavish H, Shannon WR, Buchwald M. Cloning of cDNAs for Fanconi's anaemia by functional complementation. Nature. 1992;356:763-767.
10. de Winter JP, Leveille F, van Berkel CGM, et al. Isolation of a cDNA representing the Fanconi Anemia Complementation Group E gene. Am J Hum Genet. 2000;67:1306-1308.
11. de Winter JP, Rooimans MA, van der Weel L, et al. The Fanconi anemia complementation gene FANCF encodes a novel protein with homology to ROM. Nat Genet. 2000;24:15-16.
12. de Winter JP, Waisfisz Q, Rooimans MA, et al. The Fanconi anaemia group G gene is identical with human XRCC9. Nat Genet. 1998;20:281-283.
13. Garcia-Higuera I, Taniguchi T, Ganesan S, et al. Interaction of the Fanconi anemia proteins and BRCA1 in a common pathway. Mol Cell. 2001;7:249-262.
14. de Winter JP, van Der Weel L, de Groot J, et al. The Fanconi anemia protein FANCF forms a nuclear complex with FANCA, FANCC and FANCG. Hum Mol Genet. 2000;9:2665-2674,
15. Medhurst AL, Huber PAJ, Waisfisz Q, de Winter JP, Mathew CG. Direct interactions of the five known Fanconi anaemia proteins suggest a common functional pathway. Hum Mol Genet. 2001;10:423-429.
16. Sala-Trepat M, Rouillard D, Escarceller M, Laquerbe A, Moustacchi E, Papadopoulo D, Arrest of S-phase progression is impaired in Fanconi anemia cells. Exp Cell Res. 2000;260:208-215.
17. Centurion SA, Kuo H-R, Lambert WC. damage-resistant DNA synthesis in Fanconi anemia cells treated with a DNA cross-linking agent. Exp Cell Res. 2000;260:216-221.
18. Kaiser TN, Lojewski A, Dougherty C, Juergens L, Sahar E, Latt SA. Flow cytometric characterization of the response of Fanconi's anemia cells to mitomycin C treatment. Cytometry. 1982;2:291-297.
19. Heinrich MC, Hoatlin ME, Zigler AJ, et al. DNA cross-linker-induced G2/M arrest in group C Fanconi anemia lymphoblasts reflects normal checkpoint function. Blood. 1998;91:275-287.
20. Akkari YM, Bateman RL, Reifsteck CA, Olson SB, Grompe M. DNA replication is required to elicit cellular responses to psoralen-induced DNA inter-strand cross-links. Mol Cell Biol. 2000;20:8238-8239.
21. Akkari YM, Bateman RL, Reifsteck CA, D'Andrea AD, Olson SB, Grompe M. The 4N cell cycle delay in Fanconi anemia reflects growth arrest in late S phase. Mol Genet Metab. 2001;74:403-412.
22. Moynahan ME, Cui TY, Jasin M. Homology-directed DNA repair, mitomycin-c resistance, and chromosome stability is restored with correction of a BRCA1 mutation. Cancer Res. 2001;61:4842-4850.
23. Xu B, Kim S-T, Kastan MB. Involvement of BRCA1 in S-phase and G2-phase checkpoints after ionizing radiation. Mol Cell Biol. 2001;21:3445-3450.
24. Moynahan ME, Chiu JW, Koller BH, Jasin M. BRCA1 controls homology-directed DNA repair. Mol Cell. 1999;4:511-518.
25. Naf D, Kupfer GM, Suliman A, Lambert K, D'Andrea AD. Functional activity of the Fanconi anemia protein, FAA, requires FAC binding and nuclear localization. Mol Cell Biol. 1998;18:5952-5960.
26. Ory D, Neugeboren B, Mulligan R. A stable human-derived packaging cell line for production of high-titer retrovirus/vesicular stomatitis virus G pseudotypes. Proc Natl Acad Sci U S A. 1996;93:11400-11406.
27. Kupfer G, Yamashita T, Naf D, Suliman A, Asano S, D'Andrea AD. The Fanconi anemia protein, FAC, binds to the cyclin-dependent kinase, cdc2. Blood. 1997;90:1047-1054.
28. Krude T. Mimosine arrests proliferating human cells before onset of DNA replication in a dose-dependent manner. Exp Cell Res. 1999;247:148-159.
29. Ruffner H, Jiang W, Craig AG, Hunter T, Verma IM. BRCA1 is phosphorylated at serine 1497 in vivo at a cyclin-dependent kinase 2 phosphorylation site. Mol Cell Biol. 1999;19:4843-4854.
30. Andreassen PR, Lacroix FB, Margolis RL. Chromosomes with two intact axial cores are induced by G2 checkpoint override: evidence that DNA decatenation is not required to template the chromosome structure. J Cell Biol. 1997;136:29-43.
31. 2/M transition of the cell cycle in mammalian fibroblasts. Proc Natl Acad Sci U S A. 1999;96:11335-11340.
32. Scully R, Chen J, Ochs RL, et al. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage. Cell. 1997;90:425-435.
33. Lee J-S, Collins KM, Brown AL, Lee C-H, Chung JH. hCds1-mediated phosphorylation of BRCA1 regulates the DNA damage response. Nature. 2000;404:201-204.
34. Li S, Ting NSY, Zheng L, et al. Functional link of BRCA1 and ataxia telangiectasia gene product in DNA damage response. Nature. 2000;406:210-215.
35. Baumann P, West SC. Role of the human RAD51 protein in homologous recombination and double-stranded break repair. Trends Biochem Sci. 1998;23:247-251.
36. Scully R, Chen J, Plug A, et al. Association of BRCA1 with Rad51 in mitotic and meiotic cells. Cell. 1997;88:265-275.
37. Qiao F, Moss A, Kupfer GM. Fanconi anemia proteins localize to chromatin and the nuclear matrix in a DNA damage- and cell cycle-regulated manner. J Biol Chem. 2001;276:23391-23396.
38. Cortez WJ, Wangt Y, Qin J, Eliedge SJ. Requirement of ATM-dependent phosphorylation of BRCA1 in the DNA damage response to double-strand breaks. Science. 1999;286:1162-1166.
39. Chen J. Ataxia telangiectasia-related protein is involved in the phosphorylation of BRCA1 following deoxyribonucleic acid damage, Cancer Res. 2000;60:5037-5039.
40. Tibbetts RS, Cortez D, Brumbaugh KM, et al. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev. 2000;14:2989-3002.
41. Maya R, Balass M, Kim ST, et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 2001;15:1067-1077.
42. Haber JE. DNA recombination: the replication connection. Trends Biochem Sci. 1999;24:271-275.
43. Kowalczykowski SC. Initiation of genetic recombination and recombination-dependent replication. Trends Biochem Sci. 2000;25:156-165.